Singapore becomes home-base of biomedical firms

In 2009 biomedical sciences investments amounted to S$1.2 billion in total fixed asset investment and S$700 million in total business spending.

According to the Singapore Economic Development Board (EDB), "In 2009, global biomedical sciences companies have located strategic functions in Singapore that include regional headquarters (e.g. Medtronic, Quintiles, Takeda), first-in-Asia and global manufacturing facilities (e.g. GlaxoSmithKline, Illumina, Lonza, Medtronic, ResMed, Roche) and R&D bases in Asia (e.g. Abbott, 3M, Merck, Roche, Inviragen, FORMA)."

Singapore's biomedical manufacturing output in 2009 grew steadily to about S$21 billion and employed more than 13,000 people. Current investments, when fully implemented, will create more than 1,600 jobs for professionals, managers, engineers, research scientists and engineers, and skilled workers.

Mr Julian Ho, EDB Assistant Managing Director, said, "The global biomedical sciences industry is confronted with the need to improve R&D productivity. At the same time, they need to navigate Asia’s complexities and diversity to effectively tap into the region’s fast-growing markets. As Asia’s leading bio-cluster, Singapore is well-positioned to help biomedical sciences companies accelerate their innovation and capitalise on Asia’s growth story."

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia